About Atlanthera
Atlanthera is a company based in Saint-herblain (France) founded in 2010. Atlanthera has raised $1.11 million across 1 funding round from investors including GO CAPITAL. Atlanthera operates in a competitive market with competitors including SpringWorks Therapeutics, QSAM Biosciences, Vuja De Sciences, ECM Therapeutics and Taithera, among others.
- Headquarter Saint-herblain, France
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.11 M (USD)
in 1 rounds
-
Latest Funding Round
$1.11 M (USD), Seed
Apr 13, 2014
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Atlanthera
Atlanthera has successfully raised a total of $1.11M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.11 million completed in April 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Atlanthera
Atlanthera has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include GO CAPITAL.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed toward multiple sectors.
|
Locked | Locked | Locked |
Investor details for Atlanthera
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Atlanthera
Investment portfolio details for Atlanthera
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Atlanthera
Detailed financials for Atlanthera
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Atlanthera Comparisons
Peer comparison for Atlanthera
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Atlanthera
Atlanthera operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SpringWorks Therapeutics, QSAM Biosciences, Vuja De Sciences, ECM Therapeutics and Taithera, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Small molecule therapeutics are developed for cancer and rare diseases.
|
|
| Locked | Locked | Locked |
Developer of nuclear medicines for the treatment of bone cancer treatment & bone marrow ablation
|
|
| Locked | Locked | Locked |
Therapies for preventing cancer metastasis and recurrence are developed.
|
|
| Locked | Locked | Locked |
Diagnostic and therapeutic products from extracellular matrix are developed.
|
|
| Locked | Locked | Locked |
Nanomedicine platform for targeted bone drug delivery is developed.
|
Detailed competitors of Atlanthera
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Atlanthera
Complete news archive for Atlanthera
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Atlanthera
Atlanthera was founded in 2010 and raised its 1st funding round 4 years after it was founded.
Atlanthera is headquartered in Saint-herblain, France. It is registered at Saint-herblain, Pays De La Loire, France.
Atlanthera is a funded company, having raised a total of $1.11M across 1 funding round to date.
Atlanthera was founded in 2010 as a subsidiary of Atlanta Group and is based in Saint Herblain, France. Operations are centered in the pharmaceutical sector, where small molecule drugs for bone diseases, particularly tumors, are developed. Vectorization techniques are employed to direct active pharmaceutical ingredients specifically to bone tissue, enabling local delivery of targeted molecules. A portfolio of such new molecules has been established to support these treatments.
Atlanthera's top competitors include SpringWorks Therapeutics, Vuja De Sciences and QSAM Biosciences.
Atlanthera has 1 investor. Key investors include GO CAPITAL.